Overview
Developed in response to the COVID-19 pandemic, the Rapidly Emerging Antiviral Drug Development Initiatives AViDD Center (READDI-AC) platform integrates cutting-edge discovery-based academic science with product development-oriented industrial drug development transforming the historically reactive landscape of emerging virus drug development to one that is proactive. READDI-AC components are completed in part by the creation of a FAIR-compatible data analysis platform built on HeLx, alongside Dug as a semantic search and data discovery tool.
Project Team
- Ashok Krishnamurthy (Technical Lead, Data Management Team)
- Alex Tropsha (Data Science lead, Data Management Team)
Partners
- UNC Gillings School of Global Public Health
- VUMC
- UW Madison
- NC TraCS
- Janssen Pharmaceuticals NV (JPNV)
- Takeda
- Chimerix
- Pardes Biosciences
